Superba Krill Receives FDA NDI Notification

May 26, 2011

To earn the NDI status, Aker BioMarine submitted human and animal data on scientific research and toxicology for Superba.

Superba Krill Oil has received New Dietary Ingredient (NDI) notification from FDA, according to its supplier Aker BioMarine (Oslo, Norway).

Krill oil is an emerging source of marine omega-3s eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), and astaxanthin. Due to its low level on the food chain, krill is marketed as a nutrition source with low accumulation of heavy metals.

To earn the NDI status, Aker BioMarine submitted human and animal data on scientific research and toxicology for Superba.

“Krill oil has been legally marketed in the United States for many years,” says Nils Hoem, PhD, chief scientist at Aker BioMarine.  “However, in addition to our GRAS submission already in place, we felt that our choice to submit information to FDA for review via the NDI process fully validates our safety dossier. Further, our unique manufacturing process uses ethanol, a more internationally accepted solvent.”

Superba Krill Oil is also the only krill ingredient bearing Marine Stewardship Council (MSC) Certification for sustainable fishing practices.